Dr Shaika Farooq, Dr Tabinda Farooq, Dr Khursheed Dar


INTRODUCTION: Opportunist fungal infections are on the rise due to a changing health care Paradigm. Since the data of systemic fungal
infections from our valley are scant, we conducted this study to evaluate the prevalence of fungal infections in chronic lower respiratory infections
not resolved by antibacterial chemotherapy and to observe the mycological profile from lower respiratory tract samples of such patients..
MATERIALS AND METHODS: This was a retrospective study conducted for a period of 4 years from January 2015 to Jan 2019 in the
Department of Microbiology, Government Medical College Srinagar. A total of 221 lower respiratory tract samples (148- bronchoalveolar lavage,
49- sputum, and 22-pleural fluid and 2-endo bronchial biopsy samples) were received from patients with suspected chronic non-resolving lower
respiratory tract infections from Chest Disease Hospital, Srinagar. Specimens were processed for detection of bacteria, fungi and mycobacteria as
per standard methods.
RESULTS: The most common host factors in our study population were patients with post primary pulmonary tuberculosis lesions (cavitary)
{n=70}, chronic obstructive pulmonary disease {n=20}, bronchiectasis {n=10}, non-resolving consolidation {n=70}, and uncontrolled diabetes
mellitus {n=50}.The commonest co-morbid condition associated was diabetes mellitus. The male to female ratio was 1.2:1.Out of 221 samples,
97(44.29%) tested positive for fungal elements. Sixty-five percent of fungi isolated were Aspergillus spp. Among these, Aspergillus fumigatus was
found to be the most common species isolated (16%). Scopulariopsis spp.( 6.5%) and Rhizopus spp (5%) were other molds grown on culture.
CONCLUSION: Patients with respiratory tract symptoms not responding to conventional treatment should be screened for fungi by microscopy
and culture in addition to other diagnostic modalities.


Respiratory, Fungi, Aspergillus

Full Text:



Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res. 2014; 139: 195–204.

Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses. 2014; 57 Suppl 3: 85–90.

Panda BN. Fungal infections of lungs : the emerging scenario. Indian J Tuberc. 2004; 51: 63–69.

Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017; 17: e357–e366.

Hazen KC. Mycology and aerobic Actinomyctes. In: Isenberg HD, ed. Essential Procedures for Clinical Microbiology. Washington, D.C: ASM Press, 1998:255–360.

De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008; 46: 1813–1821.

Fungal Pneumonia: Overview of Fungal Pneumonia, Risk Factors, Epidemiology of Fungal Pneumonia Accessed December 21, 2018.

Fridkin SK. The changing face of fungal infections in health care settings. Clin Infect Dis. 2005; 41: 1455–1460.

Roohani AH, Fatima N, Shameem M, Khan HM, Khan PA, Akhtar A. Comparing the profile of respiratory fungal pathogens amongst immunocompetent and immunocompromised hosts, their susceptibility pattern and correlation of various opportunistic respiratory fungal infections and their progression in relation to the CD4+T-cell counts. Indian J Med Microbiol. 2018; 36: 408–415.

Shamim S, Mitra M, Agarwal A, Ghosh B. Fungal pneumonia in intensive care unit: when to suspect and decision to treatment: a critical review. J AssocChest Physicians. 2015; 3: 41–47.

Sripriya CS, Banu ST, Deepa R, Ratnapriya N. Mycological profile of bronchial wash specimens in patients with lower respiratory tract infections. Int J Curr Microbiol Appl Sci. 2017; 6: 176–182.

Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 1980; 11: 370–376.

Shaver CM, Castilho JL, Cohen DN, et al. Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement. Am J Transplant. 2014; 14: 2893–2897.

Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzón A, Rodriguez-Tudela JL. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Chemother. 2003; 47: 2339–2341.

Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis. 2001; 33: 1692–1696.

Lass-Flörl C. The changing face of epidemiology of systemic fungal infections. European J MolClin Med. 2015; 2: 65.


  • There are currently no refbacks.